Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
+0,25%
1 104,10
+2,73
+0,25%
—1 101,371 103,631 105,311 091,41——
SIXC
Communications
SIXC
Communications
SIXC
-1,50%
604,16
-9,19
-1,50%
—613,35613,35613,35601,49——
SIXE
Energy
SIXE
Energy
SIXE
-0,09%
1 197,81
-1,02
-0,09%
—1 198,831 199,681 199,751 182,41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,88%
1 740,41
-15,54
-0,88%
—1 755,951 754,061 756,031 734,69——
SIXM
Financials
SIXM
Financials
SIXM
-0,64%
634,44
-4,07
-0,64%
—638,51637,41637,41633,05——
SIXR
Staples
SIXR
Staples
SIXR
-0,31%
840,90
-2,62
-0,31%
—843,52843,35846,40837,93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,38%
215,13
-0,82
-0,38%
—215,95215,95216,84215,06——
SIXT
Technology
SIXT
Technology
SIXT
+2,86%
3 228,71
+89,80
+2,86%
—3 138,913 189,303 230,853 174,76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,16%
935,87
+1,50
+0,16%
—934,37934,72938,26927,50——
SIXV
Health care
SIXV
Health care
SIXV
-1,37%
1 457,12
-20,31
-1,37%
—1 477,431 474,121 474,121 451,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,83%
2 399,84
+19,65
+0,83%
—2 380,192 389,342 403,042 380,47——
RDY:NYSE
Dr Reddy's Laboratories Ltd
13,67 US$
+0,66%
(+0,090) 1K
13,56 US$
-0,78% (-0,11)
Yopilgandan keyin
Savdolar yopilgan: 24-apr, 16:00:03 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
RDY tikeri uchun statistika yaratilmoqda...
Ochish
13,72 US$
Yuqori
13,83 US$
Past
13,57 US$
Bozor kapitali
11,89 mlrd
Oʻrtacha hajm
2,32 mln
Hajmi
2,63 mln
Dividend
0,67%
Choraklik dividendlar
0,02 US$
Eks-dividend sanasi
16-iyl, 2024
P/E koeffitsiyenti
18,95
52 haftalik eng yuqori
16,17 US$
52 haftalik eng past
12,77 US$
Aksiya boʻyicha daromad
0,72 US$
Beta
0,37
Muomaladagi aksiyalar
834,62 mln
Xodimlar soni
28 ming
Yangiliklar
Internetdagi manbalardan
Profil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr. Wikipedia
Dr Reddy's Laboratories Ltd haqida
CEOErez Israeli
Xodimlar soni27,8 ming
Asos solingan1984
Bosh ofislarHaydarobod, Andhra Pradesh, Hindiston
Sektor-
Veb-saytdrreddys.com
Oxirgi hisobot
21-yan, 2026
Moliya davri
Ch.3 2026
Normallashtirilgan EPS / Taxminiy
14,77/ (14,27 taxm.)INR
+3,51%musbat
Daromad / Taxminan
87,27 mlrd/ (84,52 mlrd taxm.)INR
+3,25%musbat
Q3 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
QisqachaOxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – INR
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – INR
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
85,06 mlrd
85,45 mlrd
88,05 mlrd
87,27 mlrd
Sotilgan mahsulotning tannarxi
37,80 mlrd
36,82 mlrd
39,91 mlrd
40,46 mlrd
Daromad narxi
37,80 mlrd
36,82 mlrd
39,91 mlrd
40,46 mlrd
Tadqiqot va ishlanmalarga xarajatlar
7,26 mlrd
6,24 mlrd
6,20 mlrd
6,15 mlrd
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
24,06 mlrd
25,65 mlrd
26,44 mlrd
26,92 mlrd
Operatsion xarajatlar
29,92 mlrd
31,11 mlrd
31,90 mlrd
32,48 mlrd
Jami operatsion xarajatlar
67,71 mlrd
67,94 mlrd
71,81 mlrd
72,94 mlrd
Operatsion daromad
17,35 mlrd
17,52 mlrd
16,24 mlrd
14,33 mlrd
Boshqa nooperatsion daromad
719,00 mln
-
1,28 mlrd
570,00 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
20,05 mlrd
19,05 mlrd
18,35 mlrd
15,43 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
19,76 mlrd
18,36 mlrd
17,81 mlrd
15,52 mlrd
Daromad soligʻi boʻyicha xarajat
4,18 mlrd
4,95 mlrd
4,08 mlrd
3,53 mlrd
Amaldagi soliq stavkasi
20,85%
25,99%
22,24%
22,90%
Boshqa operatsion xarajatlar
-1,40 mlrd
-779,00 mln
-740,00 mln
-591,00 mln
Sof foyda
15,94 mlrd
14,18 mlrd
14,37 mlrd
12,10 mlrd
Sof foyda marjasi
18,74%
16,59%
16,32%
13,86%
Har bir aksiya foydasi
19,84
17,02
17,87
14,77
Foizlar va investitsiyalardan olingan daromadlar
564,00 mln
1,13 mlrd
912,00 mln
796,00 mln
Foizlarni toʻlash xarajatlari
-656,00 mln
-830,00 mln
-907,00 mln
-944,00 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-92,00 mln
298,00 mln
5,00 mln
-148,00 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
20,65 mlrd
22,28 mlrd
21,29 mlrd
19,54 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-1,07 mlrd
40,00 mln
-308,00 mln
-179,00 mln
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish